I really never intended to push for any sort of hype from the company. What I wanted, that I still believe would keep investors far better informed was for trial to be in the clinical trial database, and that updates to trials where things have changed updated at least quarterly. I believe that roughly 90% of all the questions from investors would be answered by such an effort, and that it's something that most biotech companies do, even if the trials being run are purely in other countries.

Gary